ÂÜÀòÂÒÂ×

Jennifer Chien is the EVP, Head of North America at Rhythm Pharmaceuticals. Prior to this role, they were the Chief Commercial Officer at Krystal Biotech, Inc. from January 2020 to October 2020. From January 2017 to January 2020, Jennifer was the Vice President, Head of Genetic Diseases, US Rare Diseases at Sanofi Genzyme. Jennifer started their career at Genzyme, a sanofi company, in January 2007 as the Vice President, Global Head of Rare Nephrological Diseases and held this position until December 2016 when they became the Director of Corporate Development. In January 2000, Jennifer joined Genzyme Corp as a Senior Associate at Braun Consulting.

Jennifer Chien has a BA in Biology from the Massachusetts Institute of Technology and an M.S. in Health Policy & Mgmt from Harvard University.

Some of their coworkers include Yann Mazabraud - EVP, Head of International, Pam Cramer - Chief Human Resource Officer, and Linda Shapiro - Chief Medical Officer. Jennifer Chien reports to David Meeker, Chairman, President & CEO.